These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37745332)

  • 1. Linking
    Kweon SH; Ryu HG; Park H; Lee S; Kim N; Kwon SH; Ma SX; Kim S; Ko HS
    bioRxiv; 2023 Sep; ():. PubMed ID: 37745332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gba1 E326K renders motor and non-motor symptoms with pathologic α-syn, tau and glial activation.
    Kweon SH; Ryu HG; Kwon SH; Park H; Lee S; Kim NS; Ma SX; Jee HJ; Kim S; Ko HS
    Brain; 2024 Jul; ():. PubMed ID: 38976650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuronopathic GBA1L444P Mutation Accelerates Glucosylsphingosine Levels and Formation of Hippocampal Alpha-Synuclein Inclusions.
    Mahoney-Crane CL; Viswanathan M; Russell D; Curtiss RAC; Freire J; Bobba SS; Coyle SD; Kandebo M; Yao L; Wan BL; Hatcher NG; Smith SM; Marcus JN; Volpicelli-Daley LA
    J Neurosci; 2023 Jan; 43(3):501-521. PubMed ID: 36639889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocerebrosidase deficiency in dopaminergic neurons induces microglial activation without neurodegeneration.
    Soria FN; Engeln M; Martinez-Vicente M; Glangetas C; López-González MJ; Dovero S; Dehay B; Normand E; Vila M; Favereaux A; Georges F; Lo Bianco C; Bezard E; Fernagut PO
    Hum Mol Genet; 2017 Jul; 26(14):2603-2615. PubMed ID: 28520872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel glucosylceramide synthase inhibitor attenuates alpha synuclein pathology and lysosomal dysfunction in preclinical models of synucleinopathy.
    Cosden M; Jinn S; Yao L; Gretzula CA; Kandebo M; Toolan D; Hatcher NG; Ma L; Lemaire W; Adam GC; Burlein C; Minnick C; Flick R; Watt ML; Mulhearn J; Fraley M; Drolet RE; Marcus JN; Smith SM
    Neurobiol Dis; 2021 Nov; 159():105507. PubMed ID: 34509608
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Granek Z; Barczuk J; Siwecka N; Rozpędek-Kamińska W; Kucharska E; Majsterek I
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GBA1 deficiency negatively affects physiological α-synuclein tetramers and related multimers.
    Kim S; Yun SP; Lee S; Umanah GE; Bandaru VVR; Yin X; Rhee P; Karuppagounder SS; Kwon SH; Lee H; Mao X; Kim D; Pandey A; Lee G; Dawson VL; Dawson TM; Ko HS
    Proc Natl Acad Sci U S A; 2018 Jan; 115(4):798-803. PubMed ID: 29311330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dermal Phospho-Alpha-Synuclein Deposition in Patients With Parkinson's Disease and Mutation of the Glucocerebrosidase Gene.
    Doppler K; Brockmann K; Sedghi A; Wurster I; Volkmann J; Oertel WH; Sommer C
    Front Neurol; 2018; 9():1094. PubMed ID: 30619053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of β-Glucocerebrosidase Reduces Pathological α-Synuclein and Restores Lysosomal Function in Parkinson's Patient Midbrain Neurons.
    Mazzulli JR; Zunke F; Tsunemi T; Toker NJ; Jeon S; Burbulla LF; Patnaik S; Sidransky E; Marugan JJ; Sue CM; Krainc D
    J Neurosci; 2016 Jul; 36(29):7693-706. PubMed ID: 27445146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D409H GBA1 mutation accelerates the progression of pathology in A53T α-synuclein transgenic mouse model.
    Kim D; Hwang H; Choi S; Kwon SH; Lee S; Park JH; Kim S; Ko HS
    Acta Neuropathol Commun; 2018 Apr; 6(1):32. PubMed ID: 29703245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrastriatal injection of preformed alpha-synuclein fibrils alters central and peripheral immune cell profiles in non-transgenic mice.
    Earls RH; Menees KB; Chung J; Barber J; Gutekunst CA; Hazim MG; Lee JK
    J Neuroinflammation; 2019 Dec; 16(1):250. PubMed ID: 31796095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The L444P Gba1 mutation enhances alpha-synuclein induced loss of nigral dopaminergic neurons in mice.
    Migdalska-Richards A; Wegrzynowicz M; Rusconi R; Deangeli G; Di Monte DA; Spillantini MG; Schapira AHV
    Brain; 2017 Oct; 140(10):2706-2721. PubMed ID: 28969384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acid ceramidase involved in pathogenic cascade leading to accumulation of α-synuclein in iPSC model of GBA1-associated Parkinson's disease.
    Kumar M; Srikanth MP; Deleidi M; Hallett PJ; Isacson O; Feldman RA
    Hum Mol Genet; 2023 May; 32(11):1888-1900. PubMed ID: 36752535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutant GBA1 expression and synucleinopathy risk: first insights from cellular and mouse models.
    Sardi SP; Singh P; Cheng SH; Shihabuddin LS; Schlossmacher MG
    Neurodegener Dis; 2012; 10(1-4):195-202. PubMed ID: 22327140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synaptic dysfunction and extracellular matrix dysregulation in dopaminergic neurons from sporadic and E326K-GBA1 Parkinson's disease patients.
    Rosh I; Tripathi U; Hussein Y; Rike WA; Djamus J; Shklyar B; Manole A; Houlden H; Winkler J; Gage FH; Stern S
    NPJ Parkinsons Dis; 2024 Feb; 10(1):38. PubMed ID: 38374278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cx3cr1-deficiency exacerbates alpha-synuclein-A53T induced neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease.
    Castro-Sánchez S; García-Yagüe ÁJ; López-Royo T; Casarejos M; Lanciego JL; Lastres-Becker I
    Glia; 2018 Aug; 66(8):1752-1762. PubMed ID: 29624735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gaucher-related synucleinopathies: the examination of sporadic neurodegeneration from a rare (disease) angle.
    Sardi SP; Cheng SH; Shihabuddin LS
    Prog Neurobiol; 2015 Feb; 125():47-62. PubMed ID: 25573151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-related biphasic effect of the Parkinson's disease neurotoxin MPTP, on the spread, accumulation, and toxicity of α-synuclein.
    Merghani MM; Ardah MT; Al Shamsi M; Kitada T; Haque ME
    Neurotoxicology; 2021 May; 84():41-52. PubMed ID: 33549656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained Systemic Glucocerebrosidase Inhibition Induces Brain α-Synuclein Aggregation, Microglia and Complement C1q Activation in Mice.
    Rocha EM; Smith GA; Park E; Cao H; Graham AR; Brown E; McLean JR; Hayes MA; Beagan J; Izen SC; Perez-Torres E; Hallett PJ; Isacson O
    Antioxid Redox Signal; 2015 Aug; 23(6):550-64. PubMed ID: 26094487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Molecular Impact of Glucosylceramidase Beta 1 (Gba1) in Parkinson's Disease: a New Genetic State of the Art.
    Dos Santos JCC; Mano GBC; da Cunha Barreto-Vianna AR; Garcia TFM; de Vasconcelos AV; Sá CSG; de Souza Santana SL; Farias AGP; Seimaru B; Lima MPP; Goes JVC; Gusmão CTP; Junior HLR
    Mol Neurobiol; 2024 Feb; ():. PubMed ID: 38347286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.